Fujii, T.; Nakano, Y.; Hagita, D.; Onishi, N.; Endo, A.; Nakagawa, M.; Yoshiura, T.; Otsuka, Y.; Takeuchi, S.; Suzuki, M.;
et al. KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway. Cancers 2024, 16, 9.
https://doi.org/10.3390/cancers16010009
AMA Style
Fujii T, Nakano Y, Hagita D, Onishi N, Endo A, Nakagawa M, Yoshiura T, Otsuka Y, Takeuchi S, Suzuki M,
et al. KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway. Cancers. 2024; 16(1):9.
https://doi.org/10.3390/cancers16010009
Chicago/Turabian Style
Fujii, Takashi, Yoshiko Nakano, Daichi Hagita, Nobuyuki Onishi, Arumu Endo, Masaya Nakagawa, Toru Yoshiura, Yohei Otsuka, Satoru Takeuchi, Mario Suzuki,
and et al. 2024. "KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway" Cancers 16, no. 1: 9.
https://doi.org/10.3390/cancers16010009
APA Style
Fujii, T., Nakano, Y., Hagita, D., Onishi, N., Endo, A., Nakagawa, M., Yoshiura, T., Otsuka, Y., Takeuchi, S., Suzuki, M., Shimizu, Y., Toyooka, T., Matsushita, Y., Hibiya, Y., Tomura, S., Kondo, A., Wada, K., Ichimura, K., & Tomiyama, A.
(2024). KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway. Cancers, 16(1), 9.
https://doi.org/10.3390/cancers16010009
